Fortune Business Insights has announced the release of a market assessment report on "Global Neuromodulation Devices Market Size, Share, Trend Analysis Report, By Type, By Processing, By Distribution Channel, Market Outlook and Industry Analysis 2032."
Fortune Business Insights Report has released its latest report on "Neuromodulation Devices Market Size 2025." The report provides a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR forecasts, and emerging opportunities to help companies identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this research is a valuable resource for companies looking to stay competitive and capitalize on market potential.
The global neurostimulators market size was valued at USD 6.21 billion in 2024. The market is projected to grow from USD 6.71 billion in 2025 to USD 11.69 billion by 2032, exhibiting a CAGR of 8.3% during the forecast period.
Get a Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100561
Latest FDA Approval
The FDA has approved several AI-enabled medical devices that are essential to smart hospital infrastructure, including advanced radiology systems such as Fujifilm's ECHELON Synergy MRI and Shanghai United Film's uMI Panvivo, enhancing diagnostic accuracy and workflow automation.
To streamline the approval process and ensure ongoing safety without repeat marketing applications, the FDA has finalized guidance on changes to AI-powered devices through proactive change control plans (PCCPs).
The major Neuromodulation Devices Market manufacturers profiled in the market report are:
This market is dominated by major players such as Boston Scientific, Abbott, Riva Nova, and Medtronic, whose strong distribution networks and technologically advanced product portfolios help them dominate the global market.